| Report: Biotech VCs Perpetuate Boardroom Gender Gap | Alex Lash | 01/24/17 | National |
| Q3 Venture Funding Surges Near Record Levels, and Top 10 Deals | Bruce V. Bigelow | 10/16/15 | National |
| Crossing Sand Hill: A Q&A With Biotech Venture Vet Nina Kjellson | Alex Lash | 09/30/15 | San Francisco |
| Out of the Digital Health Fog, More Investments Are Coming in 2015 | Wende Hutton | 06/29/15 | National |
| Glooko Gets $16M Injection to Upgrade Digital Diabetes Product | Alex Lash | 03/17/15 | San Francisco |
| West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More | Alex Lash | 03/05/15 | San Francisco |
| “Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap | Alex Lash | 03/04/15 | San Francisco |
| In the Jiu-Jitsu Match of Biotech Risk, a Reminder of Other Paths | Alex Lash | 01/20/15 | National |
| As Atlas Splits, Is There A Case To Make In Venture For Specialists? | Alex Lash | 10/22/14 | National |
| Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year | Alex Lash | 10/16/14 | New York |
| Which VCs Are Poised to Profit From the Biotech IPO Boom? | Luke Timmerman | 09/09/13 | National |
| West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News | Bruce V. Bigelow | 04/21/11 | San Diego |
| In This Corner: Kinsella & More Vs. Hutton & Samuels on Venture Biotech | Bruce V. Bigelow | 04/18/11 | San Diego |
| As Kinsella Affair Goes Global, Sofinnova’s Papiernik Says Don’t Blame Big Pharma for Weak Biotech Ventures | Bruce V. Bigelow | 03/30/11 | San Diego |
| Canaan Strings Together Some Good News, Just as the Pressure Mounts on VC Model | Luke Timmerman | 03/24/11 | San Francisco |
